Last reviewed · How we verify
NCT04818268
Sensory Memory in Speech Motor Learning
NA trial testing Adaptation in Speech in 120 participants. Terminated before completion.
31 July 2025
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 120 |
| Start date | 1 August 2019 |
| Primary completion | 31 July 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Adaptation
- cTBS
Conditions studied
- Speech — all drugs for Speech →
- Consolidation — all drugs for Consolidation →
Sponsor
Yale University
Who can join
Adults 21 to 40, any sex, with Speech or Consolidation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed studies focus on memory for speech movements and sounds and its relation to learning. Continuous theta-burst transcranial magnetic stimulation (cTBS) will be used to suppress activity in a region of pre-frontal cortex associated with somatic and auditory working memory (Brodmann area 46v) to test its involvement in learning.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04818268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Adaptation
Trials testing the same drug.
- NCT06467305 — Speech Motor Learning and Retention (Aim 1) · NA · recruiting
- NCT06467292 — Speech Motor Learning and Retention (Master Protocol) · NA · recruiting
- NCT06491823 — Speech Motor Learning and Retention (Aim 2) · NA · recruiting
- NCT04818021 — Contribution of the Somatosensory System to Speech Perceptual Processing · NA · terminated
- NCT04497428 — Sensory Basis of Speech Motor Learning · NA · terminated
Other recruiting trials for Speech
Currently open trials in the same condition.
- NCT06479278 — Talk With Me Baby to Enhance the Early Home Language Environment · NA · recruiting
- NCT06467292 — Speech Motor Learning and Retention (Master Protocol) · NA · recruiting
- NCT06491823 — Speech Motor Learning and Retention (Aim 2) · NA · recruiting
- NCT06467305 — Speech Motor Learning and Retention (Aim 1) · NA · recruiting
- NCT06589570 — Intelligibility and Acoustic Speech Performance of CAD/CAM Milled Titanium Partial Dentures · NA · recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04818268 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 11 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04818268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing